Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Jan 05, 2021 11:06am
227 Views
Post# 32223565

RE:News

RE:NewsSome good excerpts from Philip; "Understanding the coming revolution in cell therapy treatments of diabetes, a number of international pharmaceutical companies have advanced stem cell technologies but lack a medical device and immune protection to put it all together, making Sernovas proven technologies of great interest Philip Toleikis Dr. Toleikis contends that Sernovas Cell Pouch has solved issues of scalability, fibrosis, vascularization, cell engraftment, natural cell environment, biocompatibility and versatility through the use of human cells and tissue, as well as stem cell-derived islet cells. Anyways enough from me.
<< Previous
Bullboard Posts
Next >>